Chase Investment Counsel Corp Gilead Sciences, Inc. Transaction History

Chase Investment Counsel Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	SELL	$57.92 - $72.58 $184,011 - $230,586	-3,177 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$64.88 - $73.64 $1,816 - $2,061	28 Added 0.89%	3,177 $230,000
Q3 2021 Nov 04, 2021	BUY	$67.69 - $73.03 $6,024 - $6,499	89 Added 2.91%	3,149 $219,000
Q2 2021 Jul 29, 2021	BUY	$63.47 - $69.35 $194,218 - $212,210	3,060 New	3,060 $210,000

1,879

1.02B

12M

8.96M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Chase Investment Counsel Corp, based on Form 13F filings with the SEC.

Stay updated on Chase Investment Counsel Corp with notifications on news.